Alembic Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
1,041.40
-7.35 (-0.7%)
BSENSE

Nov 20

BSE+NSE Vol: 2.04 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
2,603.48
2,149.77
1,847.72
1,876.31
1,910.15
1,710.72
1,769.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,603.48
2,149.77
1,847.72
1,876.31
1,910.15
1,710.72
1,769.64
Raw Material Cost
599.64
517.30
404.24
448.73
463.14
431.27
426.20
Purchase of Finished goods
177.22
120.50
129.79
143.11
126.82
109.16
92.64
(Increase) / Decrease In Stocks
-91.09
-17.72
-1.88
-62.87
-74.04
-133.02
11.77
Employee Cost
503.75
473.94
438.91
432.71
437.54
422.77
393.59
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
850.69
723.89
648.74
621.13
641.00
599.19
573.52
Total Expenditure (Excl Depreciation)
2,040.21
1,817.91
1,619.80
1,582.81
1,594.46
1,429.37
1,497.72
Operating Profit (PBDIT) excl Other Income
563.27
331.86
227.92
293.50
315.69
281.35
271.92
Other Income
15.11
14.93
25.50
15.50
6.91
6.50
14.19
Operating Profit (PBDIT)
578.38
346.79
253.42
309.00
322.60
287.85
286.11
Interest
38.26
27.61
22.56
23.31
24.23
23.52
24.52
Exceptional Items
0.00
0.00
-24.76
-42.23
0.00
0.00
0.00
Gross Profit (PBDT)
540.12
319.18
206.10
243.46
298.37
264.33
261.59
Depreciation
100.80
97.71
88.59
80.12
76.07
73.77
68.99
Profit Before Tax
437.95
221.86
118.62
161.50
223.72
190.11
191.94
Tax
104.05
49.50
-82.91
29.55
40.01
36.48
35.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
335.27
171.97
200.42
133.79
182.29
154.08
157.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
335.27
171.97
200.42
133.79
182.29
154.08
157.29
Share in Profit of Associates
-1.37
0.39
1.11
-1.84
1.42
-0.45
-0.66
Minority Interest
-1.27
-0.71
-1.17
-1.02
-1.00
-0.75
-0.26
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
335.17
173.07
202.70
132.97
184.71
154.38
156.89
Equity Capital
39.31
39.31
39.31
39.31
39.31
39.31
39.31
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
17.05
8.81
10.31
6.77
9.4
7.85
7.98
Diluted Earnings per share
17.05
8.8
10.31
6.76
9.4
7.85
7.98
Operating Profit Margin (Excl OI)
21.64%
15.44%
12.34%
15.64%
16.53%
16.45%
15.37%
Gross Profit Margin
20.75%
14.85%
11.15%
12.98%
15.62%
15.45%
14.78%
PAT Margin
12.83%
8.02%
10.91%
7.03%
9.62%
8.98%
8.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2026 is 36.30% vs 15.91% in Sep 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2026 is 81.46% vs 20.40% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2026 is 78.43% vs 31.94% in Sep 2025

stock-summary

Interest

YoY Growth in quarter ended Sep 2026 is 57.90% vs 28.81% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025

Compare Quarterly Results Of Alembic Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,603.48
1,559.98
1,043.50
66.89%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,603.48
1,559.98
1,043.50
66.89%
Raw Material Cost
599.64
613.15
-13.51
-2.20%
Purchase of Finished goods
177.22
0.00
177.22
(Increase) / Decrease In Stocks
-91.09
-57.06
-34.03
-59.64%
Employee Cost
503.75
258.14
245.61
95.15%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
850.69
408.15
442.54
108.43%
Total Expenditure (Excl Depreciation)
2,040.21
1,222.39
817.82
66.90%
Operating Profit (PBDIT) excl Other Income
563.27
337.59
225.68
66.85%
Other Income
15.11
10.69
4.42
41.35%
Operating Profit (PBDIT)
578.38
348.28
230.10
66.07%
Interest
38.26
20.97
17.29
82.45%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
540.12
327.31
212.81
65.02%
Depreciation
100.80
83.87
16.93
20.19%
Profit Before Tax
437.95
243.42
194.53
79.92%
Tax
104.05
61.59
42.46
68.94%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
335.27
181.84
153.43
84.38%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
335.27
181.84
153.43
84.38%
Share in Profit of Associates
-1.37
0.00
-1.37
Minority Interest
-1.27
0.00
-1.27
Other related items
0.00
0.00
0.00
Consolidated Net Profit
335.17
181.84
153.33
84.32%
Equity Capital
39.31
27.28
12.03
44.10%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
17.05
6.67
10.38
155.62%
Diluted Earnings per share
17.05
7.03
10.02
142.53%
Operating Profit Margin (Excl OI)
21.64%
21.95%
0.00
-0.31%
Gross Profit Margin
20.75%
21.28%
0.00
-0.53%
PAT Margin
12.83%
11.82%
0.00
1.01%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,603.48 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 21.11% vs 16.35% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 36.30% vs 15.91% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 335.17 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 93.66% vs -14.62% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 81.46% vs 20.40% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 563.27 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 69.73% vs 45.60% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 78.43% vs 31.94% in Sep 2025

Quarterly - Interest
Interest 38.26 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 38.57% vs 22.38% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 57.90% vs 28.81% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.64%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025